Cinchonan-9-ol,6'-methoxy-,(8R,9R)-,sulfate (2:1) (salt),mixt. with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6- dione compd. with 1,2-ethanediamine (2:1) (91160-66-6)
Identification |
Properties |
Safety Data |
|
|
Other Product
- L-Ascorbic acid,compounds,mixt. with 3-[[6-O-(6-deoxy-R-L-mannopyranosyl)-â- D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)- 5,7-dihydroxy-4H-1-benzopyran-4- one,5-(1,2-dihydroxyethyl)-3,4-dihydroxy-2- (5H)-furanone,4-(dimethylamino)-1,2- dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol- 3-one and (8R,9R)-6'-methoxycinchonan-9-ol sulfate (2:1) (salt)
- Cinchonan-9-ol,6'-methoxy-, hydrochloride (1:1), (8alpha,9R)-
- Cinchonan-9-ol,6'-methoxy-, hydrobromide (1:1), (8a,9R)-
- Cinchonan-9-ol,6'-methoxy-, hydriodide (1:1), (8a,9R)-
- 2-hydroxybenzoic acid - (9R)-cinchonan-9-ol (1:1)
- 3-Pyridinecarboxylic acid,compounds,compd. with 3,7-dihydro-7-[2-hydroxy-3-[(2- hydroxyethyl)methylamino]propyl]-1,3- dimethyl-1H-purine-2,6-dione (1:1),mixt. with pentosan sulfates
- Cinchonan-9-ol,6'-methoxy-, 1-oxide, (8a,9R)-
- Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with 2-(acetyloxy)benzoic acid, 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-5- (3-methylbutyl)-,mixt. with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6- dione compd. with 1,2-ethanediamine (2:1) and (RR)-R-[(1S)-1-(methylamino)ethyl]- benzenemethanol
- Cinchonan-9-ol,10,11-dihydro-6'-methoxy-, hydrobromide, hydrate (1:1:?), (8a,9R)-
- 2-Propenoic acid, 3-phenyl-, compd with (8alpha,9R)-6-methoxycinchonan-9-ol (1:1)
- 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-[(phenoxyacetyl)- amino]-,(2S,5R,6R)-,mixt. with 4-amino-N-(6-methoxy-3-pyridazinyl)- benzenesulfonamide and 3,7-dihydro-1,3-dimethyl-1H-purine-2,6- dione
- (8α,9R)-6'-methoxycinchonan-9-ol, salt with [(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino]methanesulphonic acid (1:1)
- Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3- methoxy-17-methyl-,(5R,6R)-,phosphate (1:1) (salt),mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione,4-(dimethylamino)-1,2-dihydro-1,5- dimethyl-2-phenyl-3H-pyrazol-3-one,N-(4-ethoxyphenyl)acetamide and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)- pyrimidinetrione
- Ergotaman-3,6,18-trione, 9,10-dihydro-12-hydroxy-2-methyl-5-(phenylmethyl)-, (5alpha,10alpha)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (2:1) (salt), mixt. with (5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol phosphate (1:1) (salt), 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 5-ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
- 7-acetyl-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione, compound with 6-amino-2-methylheptan-2-ol (1:1)
- Benzoic acid,2-hydroxy-,compounds,calcium salt (2:1),mixt. with 3,7-dihydro-3,7-dimethyl-1H-purine-2,6- dione calcium salt
- Benzoic acid, 2-hydroxy-, calcium salt (2:1), mixt. with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione calcium salt
- Heparin, compd. with 7-(2-(diethylamino)ethyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1)
- Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3- methoxy-17-methyl-,(5R,6R)-,phosphate (1:1) (salt),mixt. with (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3- yl R-(hydroxymethyl)benzeneacetate sulfate (2:1) (salt),sodium [(2,3-dihydro-1,5-dimethyl-3- oxo-2-phenyl-1H-pyrazol-4-yl)methylamino]- methanesulfonate and N,N,R-trimethyl-10H-phenothiazine-10- ethanamine monohydrochloride